Wednesday, February 17, 2021 9:36:05 AM
"Some news from RedHill Biopharma (RDHL) this morning as well as a Motley Fool user recommendation on RedHill. They have oral pills for COVID, now including one for mild-to-moderate being tested in a home environment (just dosed first patient in Phase2/3), and one for more severe (topline results expected in Q2). Different mode of action than everyone else. Just for info. A number of these Israeli stocks ride up quick on news and then taper back down almost as fast."
Their home testing appears to be nurse-supervised and electronically supervised in some way to assure accuracy. Interesting.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM